Last updated: 2026-10-12 19:17:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
STERIS plc (STE) operates in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES sector and is listed on NYSE. The stock is currently priced at $218,43, with a market capitalization of $20,90B and a P/E ratio of 25,96. Over the past 52 weeks, its price has ranged from $195,14 to $269,44. This page covers its latest market performance, valuation, price trends and company information.
$20,90B | |
$216,09 | |
$269,44 | |
$19,20 | |
$214,40 | |
458,74K | |
683,98K | |
25,96 | |
$269,44 | |
$195,14 | |
1,18% | |
-- |
STERIS plc (STE) is currently trading at $218,43 as of 2026-10-12 19:00:51, up 1,88% ($4,03) from the previous close of $214,40
During today's regular trading session, STE has traded between $19,20 and $269,44, with a trading volume of 458,74K shares. The current price is near the upper end of today's range.
Over the past seven days, STERIS plc (STE) moved from $209,34 to $218,43, representing a gain of 4,34% ($9,09).
The stock traded between $206,53 and $220,73 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 677,02 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 31,3%
STE is currently trading at $218,43, placing it 31,3% of the way from its 52-week low of $195,14 to its 52-week high of $269,44. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
| Industry | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Employees | 17937 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of STERIS plc (STE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.